Session Details
[O13]Cancer Genetics 3
Fri. Nov 20, 2026 9:40 AM - 10:40 AM JST
Fri. Nov 20, 2026 12:40 AM - 1:40 AM UTC
Fri. Nov 20, 2026 12:40 AM - 1:40 AM UTC
Room 7 (Grand Hall, Sendai Ryokusaikan Visitor Center)
Chair: Issei Imoto (Aichi Cancer Center), Manabu Muto (Kyoto University)
[O13-01]Clinical management of secondary findings in hematologic malignancy panel testing: a single-institution analysis
Yurika Suzuki1, Tomohiro Kubo1, Hayato Watabe1, Masahiro Yoshida2, Satoshi Iyama2, Masashi Idogawa3, Masayoshi Kobune2, Kohichi Takada1 (1. Division of Medical Oncology, Department of Internal Medicine, Sapporo Medical University School of Medicine, Sapporo, Japan, 2. ivision of Hematology, Department of Internal Medicine, Sapporo Medical University School of Medicine, 3. Division of Medical Genome Sciences, Department of Genomic and Preventive Medicine, Sapporo Medical University School of Medicine)
[O13-02]Pan-cancer germline findings beyond BRCA1/2 in 8,109 paired tumor-normal CGP cases
Eri Habano1,2, Miho Ogawa3,4, Kosuke Watanabe3,4, Nana Akiyama4, Hyangri Chang4, Eri Shijiki4, Akiko Kunita3, Shuich Tsutsumi5, Kenji Tatsuno5, Hiroyuki Aburatani5, Hidenori Kage6, Katsutoshi Oda1,4 (1. Division of Integrative Genomics Graduate School of Medicine, The University of Tokyo, 2. Department of Clinical Genetics Oncology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3. Next-Generation Precision Medicine Development Laboratory, Graduate School of Medicine, The University of Tokyo, 4. Department of Clinical Genomics, Hospital, The University of Tokyo, 5. Research Center for Advanced Science and Technology, The University of Tokyo, 6. Department of Respiratory Medicine, Graduate School of Medicine, The University of Tokyo)
[O13-03]Clinical Genetics Collaboration for Suspected Germline Findings Triggered by Hematologic Malignancy Expert Panel Review
Motoshi Sonoda1,2, Sawako Matsuzaki2, Akiko Ishikawa2, Yumiko Taura2,3, Kanako Ishii1,2, Yuichiro Semba4,5, Koji Kato5, Yoshikane Kikushige5, Takeshi Iwasaki6, Mikita Suyama7, Yasunari Sakai1, Eishi Baba2,8, Takahiro Maeda4 (1. Department of Pediatrics, Graduate School of Medical Sciences, Kyushu University, 2. Department of Clinical Genetics, Kyushu University Hospital, 3. Department of Obstetrics and Gynecology, Graduate School of Medical Sciences, Kyushu University, 4. Division of Precision Medicine, Graduate School of Medical Sciences, Kyushu University, 5. Department of Medicine and Biosystemic Science, Graduate School of Medical Sciences, Kyushu University, 6. Department of Anatomic Pathology, Graduate School of Medical Sciences, Kyushu University, 7. Division of Bioinformatics, Medical Institute of Bioregulation, Kyushu University, 8. Department of Comprehensive Oncology, Graduate School of Medical Sciences, Kyushu University)
[O13-04]Feasibility of the Chrovis Platform for CGP Decision Support: A Concordance Study with Expert Panel Interpretations
Sakiko Naito1,2, Keita Fukuyama3, Masahiro Yoshioka1,6, Tomohiro Kondo1, Tomohiko Sunami1, Kanako Ogura5, Osamu Kikuchi1,4, Junichi Matsubara1, Kunihiro Nishimura7, Manabu Muto1 (1. Department of Clinical Oncology, Kyoto University Hospital, 2. Department of Gastroenterology and Hepatology, Tokyo Medical University, 3. Division of Medical Information Technology and Administration Planning, Kyoto University Hospital, 4. Center for Cancer Immunotherapy and Immunobiology, Kyoto University, 5. Clinical Genetics Unit, Kyoto University Hospital, 6. Department of Clinical Oncology, Kobe City Nishi-Kobe Medical Center, 7. Xcoo, Inc.)
[O13-05]DNA Degradation in Prostate Cancer Tissue: Analysis Across Multiple CGP Platforms
Sho Umegaki, Hiromichi Ebi (Center for Cancer Genomics and Advanced Therapeutics, Aichi Cancer Center, Aichi, Japan)
[O13-06]Clinical interpretation of low variant allele fraction variants in blood-based hereditarycancer testing
Akito Dobashi1,2, Hiromi Arakawa1, Asami Kuga1, Eri Habano1, Yuko Minoura1, Keika Kaneko1, Arisa Ueki1 (1. Department of Clinical Genetics, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan, 2. Department of Pathology / Pathology Project for Molecular Targets, The Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan)
